Skip to product information
1 of 1

AILEDX(Alectinib) АЙЛЕКС (алектиниб)

AILEDX(Alectinib) АЙЛЕКС (алектиниб)

View full details
Packaging Size: 56 capsules per bottle
Strength: 150 mg
Composition: Alectinib 150 mg (equivalent to 161.33 mg Alectinib HCl)
Treatment: ALK-positive metastatic non-small cell lung cancer (NSCLC)
Form: Capsules
Brand: LuciAle
Quantity Unit: Capsules
Manufacturer: Lucius Pharmaceuticals (Lao) Co., Ltd.


AILEDX (Alectinib) is a targeted anticancer medicine containing alectinib, a selective inhibitor of anaplastic lymphoma kinase (ALK). It works by blocking abnormal ALK signaling pathways that can promote the growth and survival of cancer cells.

Alectinib is primarily used for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC). It may be used in different treatment settings depending on the patient’s disease stage and clinical circumstances. AILEDX should be used under the supervision of a qualified healthcare professional and after appropriate molecular testing has confirmed ALK-positive disease.




Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.